Figure 22.
(a–d) In vivo biocompatibility of HA/SF-5% (black arrows denote lymphocytes, eosin and haematoxylin staining). (e–h) Increment of lymphocytes at the implantation site between control and experimental groups [187]
(a–d) In vivo biocompatibility of HA/SF-5% (black arrows denote lymphocytes, eosin and haematoxylin staining). (e–h) Increment of lymphocytes at the implantation site between control and experimental groups [187]